TARA RICE: Open Payments
NPI 1538449772 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,675 in 148 payments from 21 companies in 2025. Trend: 2023 $3,192 · 2024 $3,095 · 2025 $2,675
Food & beverage: $2,675
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $540 |
| GlaxoSmithKline, LLC. | 19 | $365 |
| PFIZER INC. | 14 | $276 |
| AstraZeneca Pharmaceuticals LP | 11 | $274 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $159 |
| Lilly USA, LLC | 9 | $147 |
| Astellas Pharma US Inc | 8 | $145 |
| Ardelyx, Inc. | 5 | $145 |
| Esperion Therapeutics, Inc. | 6 | $127 |
| Axsome Therapeutics, Inc. | 5 | $115 |
Products named: TRELEGY ELLIPTA, ELIQUIS, VRAYLAR, FARXIGA, Kerendia, Veozah, IBSRELA, NEXLETOL.
Industry payments across LA — which companies pay providers there.
